Sold as Gynorest. Every FDA application for this active ingredient.
As of Nov 14, 2026, FDA lists 1 application for Dydrogesterone (sold as Gynorest), with 0 new uses approved and 0 published complete response letters.
| Clinical Efficacy And Safety of Dydrogesterone In The Treatment Of Abnormal Uterine Bleeding During PubertyAbnormal Uterine Bleeding (AUB), Ovulation Dysfunction · Guangdong Women and Children Hospital | — | Recruiting | Jul 14, 2026 |
| Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) CyclesInfertility, Endometrial Peristalsis · Mỹ Đức Hospital | — | Recruiting | Jun 30, 2026 |
| The Research of Integrated Traditional Chinese and Western Medicine on Hypothalamic AmenorrheaFunctional Hypothalamic Amenorrhea · Peking Union Medical College Hospital | Phase 4 | Recruiting | May 12, 2026 |
| Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone TherapyMenopausal Women, Menopausal Symptom Relief · Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | Not applicable | Not yet recruiting | Mar 27, 2026 |
| A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed AbortionMissed Abortion, Early Pregnancy Failure · The Third Xiangya Hospital of Central South University | Not applicable | Recruiting | Feb 20, 2026 |
| Clinical Study on the Effect of Umbilical Cord Mesenchymal Stem Cell Exosomes on Endometrial Repair of Intrauterine AdhesionsIntrauterine Adhesions, Exosomes · Sixth Affiliated Hospital, Sun Yat-sen University | Not applicable | Active, not recruiting | Feb 18, 2026 |
| IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist ProtocolsInfertility (IVF Patients), Embryo Morphokinetics · Hanoi Medical University | Not applicable | Recruiting | Feb 13, 2026 |
| Multifaceted Benefits of Auricular Point Sticking for IVF Patients: Psychological Well-being, Sleep, and Treatment OutcomesInfertility, Female, Anxiety · Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | Not applicable | Enrolling by invitation | Feb 13, 2026 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
